Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency (original ) (raw )Donor type natural killer cells after haploidentical T cell-depleted bone marrow stem cell transplantation in a patient with adenosine deaminase-deficient severe combined immunodeficiency
Atwood Gaines
Clinical immunology and immunopathology, 1991
View PDFchevron_right
Hematopoietic Cell Transplantation for Adenosine Deaminase Severe Combined Immunodeficiency—Improved Outcomes in the Modern Era
Eleri Williams
Journal of Clinical Immunology, 2022
View PDFchevron_right
Immunoreconstitution by Peripheral Blood Leukocytes in Adenosine Deaminase-deficient Severe Combined Immunodeficiency
Kenneth Rich
Journal of Clinical Investigation, 1980
View PDFchevron_right
T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency
Donald Kohn
Archivum Immunologiae et Therapiae Experimentalis
View PDFchevron_right
T-cell replete haploidentical bone marrow transplantation for X-linked severe combined immunodeficiency
Vida Jawin
Singapore Medical Journal, 2018
View PDFchevron_right
Neonatal bone marrow transplantation for severe combined immunodeficiency
M. Abinun , Bruce Crooks
Archives of Disease in Childhood - Fetal and Neonatal Edition, 2001
View PDFchevron_right
Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies
juan ortega
Bone Marrow Transplantation, 2008
View PDFchevron_right
Long-term Clinical Outcome of Patients with Severe Combined Immunodeficiency (SCID) after Non-Ablative Related Donor Bone Marrow Transplantation
Rebecca Buckley
Journal of Allergy and Clinical Immunology, 2008
View PDFchevron_right
Serial transplantation of mismatched donor hematopoietic cells between HLA-identical sibling pairs with congenital immunodeficiency: in vivo tolerance permits rapid immune reconstitution following T-replete transplantation without GVHD in the secondary recipient
Alison Jones
Blood, 2006
View PDFchevron_right
Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: Need for safer conditioning and reduced late effects
Morton Cowan
Journal of Allergy and Clinical Immunology, 2013
View PDFchevron_right
Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency
Petr Sedlacek , Morton Cowan
Journal of Allergy and Clinical Immunology, 2014
View PDFchevron_right
Matched unrelated bone marrow transplant for severe combined immunodeficiency
Ilan Dalal
Immunologic Research, 2007
View PDFchevron_right
Successful unrelated cord blood transplantation in two children with severe combined immunodeficiency syndrome
Massimo Berger
Bone Marrow Transplantation, 2003
View PDFchevron_right
Relevance of donor source to T-cell regeneration after bone marrow transplantation for severe combined immunodeficiency
Duilio Brugnoni
Haematologica, 1999
View PDFchevron_right
Successful bone marrow transplantation in children with severe aplastic anemia using HLA-partially matched family donors
Vito Vitale
American Journal of Hematology, 1993
View PDFchevron_right
Haploidentical peripheral blood stem cell transplantation with a combination of CD34 selection and T cell depletion as graft-versus-host disease prophylaxis in a patient with severe combined immunodeficiency
Jyoti Kotwal
Bone Marrow Transplantation, 1997
View PDFchevron_right
Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants
Emanuele Angelucci
Bone Marrow Transplantation, 2000
View PDFchevron_right
T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates
Thomas Bowen
Nature Medicine, 1998
View PDFchevron_right
Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency
Joel Brochstein
Vox sanguinis, 1986
View PDFchevron_right
In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID)
M. Abinun
Bone Marrow Transplantation, 1997
View PDFchevron_right
T-lymphocyte differentiation in vitro in severe combined immunodeficiency. Defects of stem cells
Savita Pahwa
Journal of Clinical Investigation, 1979
View PDFchevron_right
Unrelated Donor Bone Marrow Transplants in Children
Elliot Landaw
Cell Transplantation, 1994
View PDFchevron_right
Non-Myeloablative Stem Cell Transplantation for Congenital Immunodeficiencies
Graham Davies
Recent Results in Cancer Research, 2002
View PDFchevron_right
Transplacental Maternal Engraftment and Post-Transplant Graft-versus-Host Disease in Children with Severe Combined Immunodeficiency
Morton Cowan
Journal of Allergy and Clinical Immunology, 2017
View PDFchevron_right
Allogeneic marrow grafts from donors with congenital chromosomal abnormalities in marrow cells
Jordi Barquinero
British Journal of Haematology, 1995
View PDFchevron_right
Experience with incompatible maternal donors for bone marrow transplantation
Martin Cline
Blut, 1977
View PDFchevron_right
Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction
Victoria Bordon
Science Translational Medicine, 2011
View PDFchevron_right
Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell–depleted bone marrow transplantationA retrospective European survey from the European Group for Bone Marrow Transplantation and the European Society for Immunodeficiency
Jack Vossen
The Journal of Pediatrics, 1999
View PDFchevron_right
Loss of tolerance associated with disappearance of B cells in a patient sequentially transplanted with paternal and maternal bone marrow for the treatment of severe combined immunodeficiency (SCID)
Joel Brochstein
Human Immunology, 1988
View PDFchevron_right